AKTUELLES

Münchner Gründerpreis geht an ON7, Julius Brantner Brothandwerk und mybacs® (c) Stadtsparkasse München

Münchner Gründerpreis geht an ON7, Julius Brantner Brothandwerk und mybacs®

0
Seit 1997 verleiht die Stadtsparkasse München den Münchner Gründerpreis und in der Historie finden sich prominente Namen wie FlixBus, air up, Dean & David...
Hubert Birner, Ph.D., chairman of AL-S Pharma (l.), Harry Welten, CEO AL-S Pharma (c) AL-S Pharma

AL-S Pharma appoints Harry Welten as CEO

0
Swiss biotechnology company AL-S Pharma AG has appointed Harry Welten as chief executive officer (CEO). He succeeds Michael Salzmann, Ph.D., and will lead the...
PD Dr. Matthias Schäfer, CEO der Topadur Pharma AG (l.) und Prof. Dr. med. Hubert Trübel, MBA, Geschäftsführer von ReadOn Therapeutics (c) Topadur/ ReadOn Therapeutics

DEBRA Research invests in Topadur

0
DEBRA Research gGmbH has invested in Swiss biopharmaceutical company Topadur Pharma AG to support the preclinical development of small-molecule therapies for dystrophic epidermolysis bullosa...
David Rhotert, Companisto

Rekordjahr: Companisto investiert 45 Mio. EUR in Start-ups

0
Über das Berliner Business-Angel-Netzwerk Companisto wurden 2025 insgesamt 45 Mio. EUR in Start-ups und Scale-ups investiert. Die Companisto-Gruppe erzielte damit einen Umsatz von 9,5...
Giovanni Donatelli, EnglishBusiness

Responsible translation technology essential for patient safety

0
Artificial intelligence in healthcare requires more than speed AI is rapidly transforming healthcare, helping organisations work more efficiently across administrative and clinical functions. Yet one...
stock.adobe.com, adisonpk

The right connections for the big breakthrough

0
Radiopharmacy is on the path to becoming a huge market for treatment opportunities. For start-ups, regional clusters and networks are the key for attracting...

Branchenevents